Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants.

Infection and Immunity
C HughesA P Roberts

Abstract

The sensitivity to normal human serum of 91 smooth strains of Escherichia coli isolated from urinary tract infections was determined. Production of hemolysin, which was common and associated primarily with the types O4, O6, O18, and O75, was significantly correlated with high levels of serum resistance, both within the total population and within individual O types. In contrast, serum resistance was not significantly associated with antibiotic resistance (whether transmissible or not), with colicinogeny in general, or with colicin V production in particular. This indicates that the carriage of R and ColV plasmids, shown previously to be capable of conferring increased levels of serum resistance on individual strains of E. coli isolated from other sources, does not play an important part in determining the serum sensitivity of the E. coli population involved in urinary tract infection.

References

May 1, 1977·Journal of Medical Microbiology·P W Taylor, R Parton
Apr 1, 1977·Infection and Immunity·D T Durack, P B Beeson
Feb 16, 1978·Molecular & General Genetics : MGG·V HughesG G Meynell
May 1, 1978·The Journal of Infectious Diseases·B H MinshewS Falkow
Oct 1, 1978·Infection and Immunity·P W Taylor, C Hughes
May 1, 1979·Journal of Clinical Pathology·A P Roberts, R Phillips
Jan 1, 1976·Antimicrobial Agents and Chemotherapy·V Petrocheilou, M H Richmond
Feb 1, 1975·Journal of Medical Microbiology·E M Cooke, S P Ewins
Jul 1, 1975·Journal of General Microbiology·P W Taylor
Oct 1, 1975·Kidney International·P W Taylor, K G Koutsaimanis
Jan 1, 1981·Journal of Bacteriology·A NoegelW Goebel
Jul 1, 1980·Infection and Immunity·P W Taylor, M K Robinson
Feb 1, 1981·Infection and Immunity·D L DaviesK G Hardy
Oct 1, 1981·Antimicrobial Agents and Chemotherapy·C HughesA P Roberts

❮ Previous
Next ❯

Citations

Oct 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S H JacobsonA Brauner
Jul 17, 2013·Antimicrobial Agents and Chemotherapy·L S TzouvelekisG L Daikos
Jun 1, 1985·European Journal of Clinical Microbiology·M J Harber
Jan 1, 1995·Critical Reviews in Microbiology·E M Hoffmann, J J Houle
Feb 23, 1999·The Journal of Veterinary Medical Science·K YuriA Hasegawa
Aug 29, 2009·Journal of Medical Microbiology·Poulami BhowmikT Ramamurthy
Jan 1, 1984·Molecular & General Genetics : MGG·A JuarezW Goebel
Jun 1, 1988·European Journal of Epidemiology·S BhakdiI B Holland
Jan 1, 1983·Journal of Cellular Biochemistry·M HärtleinW Goebel
Dec 1, 1985·The Journal of Hygiene·I Orskov, F Orskov
Apr 4, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L CrémetN Caroff
Jun 27, 2001·Applied and Environmental Microbiology·R PodschunU Ullmann
Jan 5, 2021·Frontiers in Microbiology·Nadia Rodríguez-MedinaUlises Garza-Ramos
Sep 2, 2019·Microbes and Infection·Trine S JensenSvend Birkelund
Sep 1, 1994·FEMS Immunology and Medical Microbiology·H PuzováJ Durovicová
Mar 17, 1999·Veterinary Microbiology·B G de BritoM C Vidotto
Dec 1, 1984·Microbiological Reviews·S J CavalieriI S Snyder
Jan 1, 1991·Clinical Microbiology Reviews·J R Johnson
Nov 1, 1985·Kidney International·M J Harber, A W Asscher
Oct 1, 1989·Kidney International·N TopleyJ D Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.